On-line range verification for proton beam therapy using spherical ionoacoustic waves with resonant frequency

Abstract In contrast to conventional X-ray therapy, proton beam therapy (PBT) can confine radiation doses to tumours because of the presence of the Bragg peak. However, the precision of the treatment is currently limited by the uncertainty in the beam range. Recently, a unique range verification met...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Taisuke Takayanagi, Tomoki Uesaka, Yuta Nakamura, Mehmet Burcin Unlu, Yasutoshi Kuriyama, Tomonori Uesugi, Yoshihiro Ishi, Nobuki Kudo, Masanori Kobayashi, Kikuo Umegaki, Satoshi Tomioka, Taeko Matsuura
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2020
Materias:
R
Q
Acceso en línea:https://doaj.org/article/738560bb3dd84384b0afdf6ce903d946
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
Descripción
Sumario:Abstract In contrast to conventional X-ray therapy, proton beam therapy (PBT) can confine radiation doses to tumours because of the presence of the Bragg peak. However, the precision of the treatment is currently limited by the uncertainty in the beam range. Recently, a unique range verification methodology has been proposed based on simulation studies that exploit spherical ionoacoustic waves with resonant frequency (SPIREs). SPIREs are emitted from spherical gold markers in tumours initially introduced for accurate patient positioning when the proton beam is injected. These waves have a remarkable property: their amplitude is linearly correlated with the residual beam range at the marker position. Here, we present proof-of-principle experiments using short-pulsed proton beams at the clinical dose to demonstrate the feasibility of using SPIREs for beam-range verification with submillimetre accuracy. These results should substantially contribute to reducing the range uncertainty in future PBT applications.